Literature DB >> 8639988

Violence and schizophrenia: clozapine as a specific antiaggressive agent.

P Buckley1, J Bartell, K Donenwirth, S Lee, F Torigoe, S C Schulz.   

Abstract

Pharmacological management of persistent aggression in patients with schizophrenia is a difficult clinical dilemma. Clozapine has been shown to be an effective agent in this regard. This study sought to compare the symptomatic response on the Brief Psychiatric Rating Scale (BPRS) between hostile schizophrenic patients and patients without aggression. While dramatic improvements were evident in aggression, both groups were indistinguishable with respect to BPRS response. These results suggest that clozapine may have a selective antiaggressive effect.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8639988

Source DB:  PubMed          Journal:  Bull Am Acad Psychiatry Law        ISSN: 0091-634X


  13 in total

Review 1.  Neuropsychiatry of aggression.

Authors:  Scott D Lane; Kimberly L Kjome; F Gerard Moeller
Journal:  Neurol Clin       Date:  2011-02       Impact factor: 3.806

2.  Clozapine Treatment and Offending: A Within-Subject Study of Patients With Psychotic Disorders in Sweden.

Authors:  Vishal Bhavsar; Kyriaki Kosidou; Linnea Widman; Nicola Orsini; John Hodsoll; Christina Dalman; James H MacCabe
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

Review 3.  Starting clozapine in the community: a UK perspective.

Authors:  Aileen O'Brien
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 4.  Pharmacological treatment of psychotic agitation.

Authors:  Glenn W Currier; Adam Trenton
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

5.  Treatment of severe borderline personality disorder with clozapine.

Authors:  Adarsh Kumar Vohra
Journal:  Indian J Psychiatry       Date:  2010-07       Impact factor: 1.759

6.  Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia.

Authors:  Jeffrey W Swanson; Marvin S Swartz; Richard A Van Dorn; Jan Volavka; John Monahan; T Scott Stroup; Joseph P McEvoy; H Ryan Wagner; Eric B Elbogen; Jeffrey A Lieberman
Journal:  Br J Psychiatry       Date:  2008-07       Impact factor: 9.319

Review 7.  From Clozapine to Cognitive Remediation.

Authors:  Jason Quinn; Nathan J Kolla
Journal:  Can J Psychiatry       Date:  2016-07-10       Impact factor: 4.356

8.  Continuing clozapine with granulocyte colony-stimulating factor in patients with neutropenia.

Authors:  Al Aditya Khan; Jake Harvey; Samrat Sengupta
Journal:  Ther Adv Psychopharmacol       Date:  2013-10

9.  Mice lacking the immediate early gene Egr3 respond to the anti-aggressive effects of clozapine yet are relatively resistant to its sedating effects.

Authors:  Amelia Gallitano-Mendel; David F Wozniak; Elizabeth A Pehek; Jeffrey Milbrandt
Journal:  Neuropsychopharmacology       Date:  2007-07-18       Impact factor: 7.853

10.  Clozapine: an effective treatment for seriously violent and psychopathic men with antisocial personality disorder in a UK high-security hospital.

Authors:  Darcy Brown; Fintan Larkin; Samrat Sengupta; Jose L Romero-Ureclay; Callum C Ross; Nitin Gupta; Morris Vinestock; Mrigendra Das
Journal:  CNS Spectr       Date:  2014-04-03       Impact factor: 3.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.